论文部分内容阅读
目的观察茵栀黄口服液联合培菲康治疗新生儿母乳性黄疸的临床疗效。方法 80例新生儿母乳性黄疸患儿随机分为观察组和对照组,各40例,对照组予人工喂养,口服培菲康治疗,观察组予人工喂养,口服培菲康,加服茵栀黄口服液,连用5 d。观察两组患儿黄疸消退时间及每天胆红素下降速度。结果观察组日均胆红素下降速度大于对照组,且下降至102.6μmol/L所需时间短,差异有统计学意义(P<0.01)。结论茵栀黄口服液联合培菲康治疗新生儿母乳性黄疸疗效确切,值得临床推广。
Objective To observe the clinical effects of Yinzhihuang oral combined with Peifei Kang in the treatment of neonatal breast milk jaundice. Methods Eighty neonates with breast milk jaundice were randomly divided into observation group (40 cases) and control group (n = 40). The control group was given artificial feeding and Peifei Kang. The observation group was given artificial feeding, Yellow oral solution, once every 5 d. Two groups of children with jaundice subsided time and daily decline in bilirubin. Results The daily average bilirubin decline rate in the observation group was larger than that in the control group, and the time required to decrease to 102.6 μmol / L was shorter, with a significant difference (P <0.01). Conclusion Yinzhihuang oral combined with Peifei Kang treatment of neonatal breast milk jaundice curative effect is worthy of clinical promotion.